Ola Skanung
Chief Executive Officer at Ledningsresurs Syd AB
Network origin in Ola Skanung first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Aptahem AB
 Aptahem AB Pharmaceuticals: MajorHealth Technology Aptahem AB operates as a biotechnology company. The firm engages in developing drug candidates for the treatment and prevention of disease caused by blockages in blood vessels as the result of blood clots, such as deep vein thrombosis, stroke and heart failure. Its main business model is to clinically develop aptamer-based treatments for life-threatening acute conditions where coagulation and inflammation interact in the disease process. The company was founded byLuiza Jedlina, Bert Junno, Tina Persson and Johan Lindh in 2014 and is headquartered in Malmo, Sweden.
11
| Public Company | Pharmaceuticals: Major | 11 |
10
| Public Company | Pharmaceuticals: Major | 10 |
Ideonfonden AB
1
| Private Company | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Ola Skanung via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| PCI BIOTECH HOLDING ASA | Biotechnology | Director/Board Member Director/Board Member | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| Karolinska Institutet | College/University | Doctorate Degree | |
| McGill University | College/University | Doctorate Degree | |
| University of Uppsala | College/University | Graduate Degree Doctorate Degree Corporate Officer/Principal | |
| University of Stockholm | College/University | Doctorate Degree | |
| Technical University of Denmark | College/University | Masters Business Admin | |
| Université de Bordeaux | College/University | Graduate Degree | |
| University of Lund | College/University | Director/Board Member Doctorate Degree Doctorate Degree Graduate Degree Undergraduate Degree | |
| Umea Universitet | College/University | Graduate Degree | |
Novation Pharmaceuticals, Inc.
 Novation Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Novation Pharmaceuticals, Inc. operates as a biotechnology research and development company. It provides modulation of intracellular messenger RNA (mRNA) to identify new small-molecule therapies to treat serious diseases. The company was founded by Dominique Cheneval and Tania Kastelic and is headquartered in Burnaby, Canada. | Medical/Nursing Services | Director/Board Member | |
| MAGFORCE AG | Medical Specialties | Founder | |
| University of Kalmar | College/University | Masters Business Admin | |
| Combio A/S | Chief Executive Officer | ||
| Swedish Pharmaceutical Society | Director/Board Member | ||
TikoMed AB
 TikoMed AB Pharmaceuticals: MajorHealth Technology TikoMed AB is a Swedish pharmaceutical company that develops pharmaceutical products. The private company is based in Viken, Sweden. The company was founded by Adam Bruce, Lars Bruce. Anders Kristensson has been the CEO of the company since 2018. | Pharmaceuticals: Major | Director/Board Member | |
| University of Linnaeus | College/University | Undergraduate Degree | |
iSD Immunotech ApS
 iSD Immunotech ApS BiotechnologyHealth Technology iSD Immunotech ApS develops immunoregulatory peptides and proteins. It conducts research and development on immunoregulatory peptides for possible applications and commercialization. The company was founded by Peter Samuel Wulff, Shervin Bahrami, Finn Skou Pedersen, Mogens Ryttergård Duch, Lars Jørgen Østergaard, Martin Tolstrup, and Martin Thygesen on August 9, 2007 and is headquartered in Aarhus, Denmark. | Biotechnology | Chief Executive Officer | |
Galecto Biotech ApS
 Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Founder Chairman | |
| Accequa AB | Chairman Chief Executive Officer Founder | ||
| EMOTRA AB (PUBL) | Medical Specialties | Director/Board Member | |
| ARCEDE PHARMA AB | Miscellaneous Commercial Services | Director/Board Member | |
| University of Detroit Mercy School of Law | College/University | Graduate Degree | |
| GABATHER AB | Pharmaceuticals: Major | Founder Director/Board Member Founder Director/Board Member | |
| OBOYA HORTICULTURE INDUSTRIES AB (PUBL) | Miscellaneous Commercial Services | Director of Finance/CFO | |
| Portendo Standoff Detection AB | Founder | ||
| Ceratmo AB | Director/Board Member | ||
| Biomedical Development Europe | Corporate Officer/Principal | ||
Edvince AB
 Edvince AB BiotechnologyHealth Technology Edvince AB engages in clinical research and development services. It operates as a biotech company that focuses on a new form of emergency treatment for stroke. The company was founded by Lars Ingvar Herbert Edvinsson in 2003 and is headquartered in Lund, Sweden. | Biotechnology | Chairman Chief Executive Officer | |
| Nordic Pharma Licensing Group | Director/Board Member | ||
| Celus Pharmaceuticals Ltd. | Chief Executive Officer | ||
Oboya Horti Supplies AB
 Oboya Horti Supplies AB Wholesale DistributorsDistribution Services Oboya Horti Supplies AB is a Swedish company that wholesales chemical products. | Wholesale Distributors | Corporate Officer/Principal | |
| Flugsvampen Hhy AB | Chairman | ||
| Pig Sverige AB | Chairman | ||
| Classic Beauty Invest AB | Corporate Officer/Principal | ||
| Classic Beauty Göteborg AB | Corporate Officer/Principal | ||
| FLUOGUIDE A/S | Pharmaceuticals: Major | Director of Finance/CFO | |
Abarceo AB
 Abarceo AB Miscellaneous Commercial ServicesCommercial Services Abarceo AB develops novel therapeutics for type-2 diabetes. It identifies a novel diabetes target located on beta cells and a novel mechanism of action enabling a therapeutic treatment to revert beta cells from dysfunctional to functional, preserving beta cell function and allowing patients to produce insulin naturally. The company was founded by Tara Heitner, Claes Wollheim, and Albert Salehi in December 2017 and is headquartered in Malmo, Sweden. | Miscellaneous Commercial Services | Founder | |
| Galecto Biotech AB | Founder Founder | ||
| Accequa GmbH | Director/Board Member Director/Board Member | ||
| Heitner Biopharm Consultation | Founder | ||
| Bainan Biotech | Director/Board Member | ||
| Aptahem Finans AB | Founder | ||
| Serstech Förvaltning AB | Founder | ||
| Mikeoo Holding AB | Founder | ||
| Holy Plantmedix AB | Founder | ||
Melius Pharma AB
 Melius Pharma AB Pharmaceuticals: MajorHealth Technology Melius Pharma AB is a Swedish clinical stage pharmaceutical company that develops new treatments for chronic cough in idiopathic pulmonary fibrosis (IPF) patients. The company is based in Lund, Sweden and is privately owned, benefiting from the support of two of Sweden's most prominent professional life science investors who bring expertise to develop the company. IPF is a chronic, progressive lung inflammation characterized by fibrosis and disruption of normal lung architecture. Melius Pharma has developed ME-015, which stabilizes ion channels in the neuronal endings in the lungs that mediate cough. ME-015 is presumed to have an acute effect and is a solution for chronic cough, which is one of the major symptoms experienced by 80%% of IPF patients. | Pharmaceuticals: Major | Director/Board Member | |
| SENSIDOSE AB | Electronic Equipment/Instruments | Director/Board Member |
Statistics
International
| Sweden | 34 |
| Denmark | 8 |
| Canada | 4 |
| Germany | 3 |
| United States | 3 |
Sectoral
| Health Technology | 12 |
| Consumer Services | 12 |
| Commercial Services | 5 |
| Finance | 2 |
| Health Services | 2 |
Operational
| Director/Board Member | 77 |
| Founder | 28 |
| Chief Executive Officer | 20 |
| Chairman | 18 |
| Corporate Officer/Principal | 18 |
Most connected contacts
- Stock Market
- Insiders
- Ola Skanung
- Company connections
